RT  - Signa Vitae
ID  - 10.22514/SV152.102019.9 
T1  - Neutrophil/lymphocyte ratio and Red blood cell distribution width are independent risk factors for 30-day mortality in Gastrointestinal system bleedingpatients
A1  - ERTUGRUL ALTINBILEK
A1  - DERYA OZTURK
A1  - CEMIL KAVALCI
K1  - emergency
K1  - mortality
K1  - NLR
K1  - RDW
YR  - 2019
SP  - 59
AB  - <p>Background: In this study, we aimed to examine demographic and endoscopic features of patients with GI bleeding to determine the factors affecting 30-day mortality. Method: Patient’s demographic features, laboratory outcomes, comor-bidities, drug use, endoscopy outcomes, Glasgow-Blatchford scores, and mortality status were examined. The factors affect-ing 30-day mortality were investigated. Results: The mean age of the patients was 58.2±17.4 years, and 72.1% were male pa-tients. 30-day mortality rate was found to be 14.4%. The mean age of patients who died was high (p&lt;0.05). The incidence of mortality was high in the presence of comorbidity, malignancy, and cirrho-sis (p&lt;0.05). Systolic blood pressure was low in the patients who died (p&lt;0.05). No significant correlation was found be-tween mortality and gender, symptoms, predisposing factors, lesion type and For-rest score, diastolic blood pressure and heart rate (p&gt;0.05). Urea, neutrophils, red blood cell distribution width / platelet ratio, neutrophil / lymphocyte ratio and RDW levels were high, and hemoglobin level was significantly low in patients with a mortal progression (p&lt;0.05). No signifi-cant correlation was found between mor-tality, and platelet and lymphocyte levels (p&gt;0.05). Glasgow-Blatchford score was significantly higher in patients who died (p&lt;0.05). Conclusion: Many factors affect 30-day mortality in GI bleeding. It should be remembered that follow-up of patients with an advanced age who have comorbid-ity and impaired hemodynamics should be kept for long, and that these patients are at a high risk for mortality.According to our results, NLR and RDW are independent factors that determine the 30-day mortality in upper GI bleeding.</p>